Life ScienceCompany
Horizon Therapeutics M&A Summary
Horizon Therapeutics has acquired 12 companies of its own, including 3 in the last 5 years. A total of 4 acquisitions came from private equity firms. It has also divested 1 asset.
Horizon Therapeutics’ largest acquisition to date was in 2021, when it acquired Viela Bio for $3.1B. It’s largest disclosed sale occurred in 2017, when it sold Raptor Pharmaceuticals to Chiesi Farmaceutici for $70M. Horizon Therapeutics has acquired in 6 different US states, and 3 countries. The Company’s most targeted sectors include life science (100%).
Horizon Therapeutics Ownership
Who owns Horizon Therapeutics?
Horizon Therapeutics is owned by Amgen. It was acquired on December 12, 2022.
Horizon Therapeutics Business Overview
Where is Horizon Therapeutics headquartered?
Horizon Therapeutics is headquartered in Dublin, Ireland.
What is Horizon Therapeutics’ revenue?
Horizon Therapeutics disclosed revenue of 3,226M USD for 2021 and 2,200M USD for 2020.
How many employees does Horizon Therapeutics have?
Horizon Therapeutics has 2,100 employees.
What sector is Horizon Therapeutics in?
Horizon Therapeutics is a life science company.
When was Horizon Therapeutics founded?
Horizon Therapeutics was founded in 2005.
M&A Summary
-
M&A Total Activity12
- M&A Buy Activity11
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 3
- M&A Buy/Sell Connections 9
- M&A Advisors 11